Chinese scientists ask for patent on US drug to fight virus
BEIJING (AP) — Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Sciences Inc. to treat the disease, possibly fueling conflict over technology policy that helped trigger Washington’s tariff war with Beijing.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
